Showing 1 - 10 of 18
We performed a cross-sectional, "bottom-up" observational study of resource consumption and quality of life of patients with multiple sclerosis (MS) in the United Kingdom. Three centers participated in the study. Patients received a questionnaire either by mail or during a clinic visit, and a...
Persistent link: https://www.econbiz.de/10001600004
We performed a cross-sectional, "bottom-up" observational study of resource consumption and quality of life of patients with multiple sclerosis (MS) in Germany. Six centers participated in the study. Patients were asked to complete a questionnaire, and a total of 737 patients returned the...
Persistent link: https://www.econbiz.de/10001600006
We performed a cross-sectional, bottom-up observational study of resource consumption and quality of life of patients with multiple sclerosis (MS) in Germany. Six centers participated in the study. Patients were asked to complete a questionnaire, and a total of 737 patients returned the...
Persistent link: https://www.econbiz.de/10010281232
We performed a cross-sectional, bottom-up observational study of resource consumption and quality of life of patients with multiple sclerosis (MS) in the United Kingdom. Three centers participated in the study. Patients received a questionnaire either by mail or during a clinic visit, and a...
Persistent link: https://www.econbiz.de/10010281304
Persistent link: https://www.econbiz.de/10010281343
SUMMARY <p> Treatment of multiple sclerosis (MS) has changed substantially during the past decade, as new biological disease-modifying treatments have been introduced in a field where only symptomatic pharmacological treatment had been available. The new treatments come at a high cost, between $...</p>
Persistent link: https://www.econbiz.de/10005190908
Persistent link: https://www.econbiz.de/10002679578
Persistent link: https://www.econbiz.de/10003375532
Persistent link: https://www.econbiz.de/10003375536
Persistent link: https://www.econbiz.de/10003375545